MACC1 and female reproductive organ cancer: High expression of MACC1 was significantly associated with shorter RFS/PFS/DFS in gynecologic cancers and breast cancer (HR = 2.37, 95%CI = 1.44–3.90, P < .01) (Fig. 3).